Search Results - "pharmacodynamics"

Association between Olaparib Exposure and Early Toxicity in BRCA-Mutated Ovarian Cancer Patients: Results from a Retrospective Multicenter Study by Maud Velev, Alicja Puszkiel, Benoit Blanchet, Sixtine de Percin, Nicolas Delanoy, Jacques Medioni, Claire Gervais, David Balakirouchenane, Nihel Khoudour, Patricia Pautier, Alexandra Leary, Zahra Ajgal, Laure Hirsch, François Goldwasser, Jerome Alexandre, Guillaume Beinse

Connect to this object online.

Renal Protective Effects of Inonotus obliquus on High-Fat Diet/Streptozotocin-Induced Diabetic Kidney Disease Rats: Biochemical, Color Doppler Ultrasound and Histopathological Evid... by Yan Zhang, Hui Liao, Dayue Shen, Xilan Zhang, Jufang Wang, Xiaohong Zhang, Xiaocheng Wang, Rongshan Li

Connect to this object online.

Population PK/PD model of tacrolimus for exploring the relationship between accumulated exposure and quantitative scores in myasthenia gravis patients by Di Chen, Qingyu Yao, Wenjun Chen, Jian Yin, Shifang Hou, Xiaoxin Tian, Ming Zhao, Hua Zhang, Liping Yang, Tianyan Zhou, Pengfei Jin

Connect to this object online.

High-Evidence, Actionable Phenotype Gene Distribution in a Multispecialty, Tertiary Care Clinic: Potentially Actionable Genes and a Referring Department Profile by Blake Bartlett, Sheena Crosby, Michael J. Schuh, Monica Bennett, Megan Miller, Madison Conway

Connect to this object online.

Pharmacokinetic of Cefiderocol in Critically Ill Patients Receiving Renal Replacement Therapy: A Case Series by Simone Mornese Pinna, Silvia Corcione, Amedeo De Nicolò, Giorgia Montrucchio, Silvia Scabini, Davide Vita, Ilaria De Benedetto, Tommaso Lupia, Jacopo Mula, Giovanni Di Perri, Antonio D'Avolio, Francesco Giuseppe De Rosa

Connect to this object online.

Population Pharmacokinetics and Dose Optimization of Ceftazidime and Imipenem in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease by Thu-Minh Nguyen, Thu-Hue Ngo, Anh-Quan Truong, Dinh-Hoa Vu, Dinh-Chi Le, Ngan-Binh Vu, Tuyet-Nga Can, Hoang-Anh Nguyen, Thu-Phuong Phan, Françoise Van Bambeke, Céline Vidaillac, Quy-Chau Ngo

Connect to this object online.

Effects of urotensin II receptor antagonist, GSK1440115, in asthma by Alison D Portnoy, Sanjay eKumar, David J Behm, Kelly M Mahr, Robert B Noble, John eThroup, Steven F Russ

Connect to this object online.

A HUMANIZED CLINICALLY CALIBRATED QUANTITATIVE SYSTEMS PHARMACOLOGY MODEL FOR HYPOKINETIC MOTOR SYMPTOMS IN PARKINSON'S DISEASE by Hugo eGeerts, Hugo eGeerts, Patrick eRoberts, Patrick eRoberts, Athan eSpiros

Connect to this object online.

Effect of adjuvant drugs on the analgesic activity of opioid morphine analgesics and compound RU-1205 by Alexander A. Spasov, Olesya Iu. Grechko, Natalya V. Eliseeva, Yuliya V. Lifanova, Angelina N. Aleksandrenkova

Connect to this object online.

Comorbid obsessive-compulsive symptoms in schizophrenia: contributions of pharmacological and genetic factors by Frederike eSchirmbeck, Mathias eZink

Connect to this object online.

Multifunctional icariin and tanshinone IIA co-delivery liposomes with potential application for Alzheimer's disease by Jiao Wang, Liang Kong, Rui-Bo Guo, Si-Yu He, Xin-Ze Liu, Lu Zhang, Yang Liu, Yang Yu, Xue-Tao Li, Lan Cheng

Connect to this object online.

Identification and neuroprotective properties of NA‐184, a calpain‐2 inhibitor by Michel Baudry, Yubin Wang, Xiaoning Bi, Yun Lyna Luo, Zhijun Wang, Zeechan Kamal, Alexander Shirokov, Ed Sullivan, Dennis Lagasca, Hany Khalil, Gary Lee, Kathy Fosnaugh, Philippe Bey, Shujaath Mehdi, Greg Coulter

Connect to this object online.

Development and Optimization of Nanolipid-Based Formulation of Diclofenac Sodium: In Vitro Characterization and Preclinical Evaluation by Ameeduzzafar Zafar, Nabil K Alruwaili, Syed Sarim Imam, Mohd Yasir, Omar Awad Alsaidan, Ali Alquraini, Alenazy Rawaf, Bader Alsuwayt, Md. Khalid Anwer, Sultan Alshehri, Mohammed M. Ghoneim

Connect to this object online.

Opioid Use Disorder Curriculum: Preclerkship Pharmacology Case-Based Learning Session by Sabrina Taldone, Sandra Lemmon, Suzy Bianco, Joan St. Onge, Henri Ford, Lindsay Cox, David P. Serota, Sabita Roy, Jason Onugha, David W. Forrest, Tyler Bartholomew, Hansel E. Tookes

Connect to this object online.

Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran by Leung TS, Law EH

Connect to this object online.

Bioactive protein fraction DLBS1033 containing lumbrokinase isolated from Lumbricus rubellus: ex vivo, in vivo, and pharmaceutic studies by Tjandrawinata RR, Trisina J, Rahayu P, Prasetya LA, Hanafiah A, Rachmawati H

Connect to this object online.

A Review on Parallel Virtual Screening Softwares for High-Performance Computers by Natarajan Arul Murugan, Artur Podobas, Davide Gadioli, Emanuele Vitali, Gianluca Palermo, Stefano Markidis

Connect to this object online.

Risk Assessment of Drug‐Induced Long QT Syndrome for Some COVID‐19 Repurposed Drugs by Veronique Michaud, Pamela Dow, Sweilem B. Al Rihani, Malavika Deodhar, Meghan Arwood, Brian Cicali, Jacques Turgeon

Connect to this object online.

A Mixture of Baicalein, Wogonin, and Oroxylin-A Inhibits EMT in the A549 Cell Line via the PI3K/AKT-TWIST1-Glycolysis Pathway by Hui-Juan Cao, Wei Zhou, Xiao-Le Xian, Shu-Jun Sun, Pei-Jie Ding, Chun-Yu Tian, Fu-Ling Tian, Chun-Hua Jiang, Ting-Ting Fu, Shu Zhao, Jian-Ye Dai, Jian-Ye Dai, Jian-Ye Dai

Connect to this object online.

Sudden death of cardiac origin and psychotropic drugs by Quadiri eTimour, Dominique eFrassati, Jacques eDescotes, Philippe eChevalier, Georges eChristé, Mohamed eChahine

Connect to this object online.